CA956232A - Attenuated live rubella virus vaccine and method of production - Google Patents

Attenuated live rubella virus vaccine and method of production

Info

Publication number
CA956232A
CA956232A CA001,858A CA1858A CA956232A CA 956232 A CA956232 A CA 956232A CA 1858 A CA1858 A CA 1858A CA 956232 A CA956232 A CA 956232A
Authority
CA
Canada
Prior art keywords
production
virus vaccine
rubella virus
attenuated live
live rubella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA001,858A
Other languages
English (en)
Inventor
Julien Peetermans
Constant Huygelen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recherche Et Industrie Trerapeutiques "rit"
Original Assignee
Recherche Et Industrie Trerapeutiques "rit"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10444820&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA956232(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Recherche Et Industrie Trerapeutiques "rit" filed Critical Recherche Et Industrie Trerapeutiques "rit"
Application granted granted Critical
Publication of CA956232A publication Critical patent/CA956232A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/20—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA001,858A 1966-10-21 1967-10-05 Attenuated live rubella virus vaccine and method of production Expired CA956232A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB47399/66A GB1135987A (en) 1966-10-21 1966-10-21 Attenuated live rubella virus vaccine and method of production

Publications (1)

Publication Number Publication Date
CA956232A true CA956232A (en) 1974-10-15

Family

ID=10444820

Family Applications (1)

Application Number Title Priority Date Filing Date
CA001,858A Expired CA956232A (en) 1966-10-21 1967-10-05 Attenuated live rubella virus vaccine and method of production

Country Status (19)

Country Link
US (1) US3686394A (de)
AT (1) AT279038B (de)
BE (1) BE705342A (de)
BR (1) BR6794003D0 (de)
CA (1) CA956232A (de)
CH (1) CH477553A (de)
CY (1) CY635A (de)
DE (1) DE1617775B1 (de)
DK (1) DK121619B (de)
ES (1) ES345972A1 (de)
FI (1) FI43625B (de)
FR (2) FR1548489A (de)
GB (1) GB1135987A (de)
IL (1) IL28696A (de)
LU (1) LU54664A1 (de)
NL (1) NL148799B (de)
NO (1) NO125776B (de)
SE (1) SE341451B (de)
YU (1) YU31804B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2129777C3 (de) * 1971-06-16 1982-04-15 Takeda Chemical Industries, Ltd., Osaka Verfahren zur Herstellung eines stark ageschwächte Rötelviren enthaltenden Impfstoffes
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
RU2213776C2 (ru) * 2001-11-20 2003-10-10 Унитарное государственное московское предприятие по производству бактерийных препаратов Минздрава РФ Способ получения адаптированного к фибробластам эмбрионов перепела вируса краснухи
US8460680B2 (en) * 2009-04-24 2013-06-11 National Health Research Institutes Polyvalent chimeric rubella virus-based vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3401084A (en) * 1965-07-29 1968-09-10 Merck & Co Inc Rubella vaccine and its preparation

Also Published As

Publication number Publication date
DE1617775B1 (de) 1970-10-22
YU31804B (en) 1973-12-31
US3686394A (en) 1972-08-22
NO125776B (de) 1972-10-30
GB1135987A (en) 1968-12-11
FR1548489A (de) 1968-12-06
BE705342A (de) 1968-03-01
NL6714223A (de) 1968-04-22
NL148799B (nl) 1976-03-15
FI43625B (de) 1971-02-01
CH477553A (fr) 1969-08-31
BR6794003D0 (pt) 1973-02-22
LU54664A1 (de) 1967-12-12
FR7321M (de) 1969-10-06
IL28696A (en) 1971-12-29
AT279038B (de) 1970-02-25
SE341451B (de) 1971-12-27
CY635A (en) 1972-03-07
DK121619B (da) 1971-11-08
ES345972A1 (es) 1968-12-01
YU203467A (en) 1973-06-30

Similar Documents

Publication Publication Date Title
CA933863A (en) Attenuated live measles virus vaccine and method of production
CA956232A (en) Attenuated live rubella virus vaccine and method of production
CA962593A (en) Highly attenuated newcastle disease virus vaccine and production thereof
CA947647A (en) Virus insecticide and method of producing same
AU413666B2 (en) Attentuated live rubella virus vaccine and method of production
AU2796167A (en) Attentuated live rubella virus vaccine and method of production
CA936095A (en) Rubella vaccine and method
CA793277A (en) Attenuated live rabies vaccine and method of preparing the same
AU262929B2 (en) Attenuated live measles virus vaccine and method of production
AU2393762A (en) Attenuated live measles virus vaccine and method of production
AU264471B2 (en) Attenuated live rabies vaccine and method of preparing thesame
CA862070A (en) Inactivated virus vaccine and process for producing same
AU2539762A (en) Attenuated live rabies vaccine and method of preparing thesame
AU407005B2 (en) Repository vaccine and method of preparing the same
CA728480A (en) Hammer and method of manufacture thereof
AU969166A (en) Repository vaccine and method of preparing the same
CA725654A (en) Bis-trimellitimidoyl chlorides and method of preparation
CA727081A (en) Parenteral vaccine and antigen compositions and methods of making and using
AU428802B2 (en) Substituted phenoxysalicylanilides and methods of preparing them
CA746918A (en) Esters and method of preparation
CA725177A (en) Indole-aldehydes and process of preparation
CA674931A (en) Hog cholera vaccine and method of making the same
AU293563B2 (en) Pertussis vaccine and method of preparation thereof
AU273015B2 (en) Freeze-dried vaccines containing attenuated measles virus and production thereof
AU2225267A (en) Substituted phenoxysalicylanilides and methods of preparing them